Cargando…

Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides

Injury to the peripheral nerves can result in temporary or life-long neuronal dysfunction and subsequent economic or social disability. Acidic fibroblast growth factor (aFGF) promotes the growth and survival of neurons and is a possible treatment for peripheral nerve injury. Yet, the actual therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanmei, Yu, Fenglin, Zhang, Beibei, Zhou, Meng, Bei, Yu, Zhang, Yifan, Tang, Jianzhong, Yang, Yan, Huang, Yadong, Xiang, Qi, Zhao, Yueping, Liang, Qian, Liu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032102/
https://www.ncbi.nlm.nih.gov/pubmed/32104478
http://dx.doi.org/10.1016/j.ajps.2018.09.007
_version_ 1783499503191457792
author Liu, Yanmei
Yu, Fenglin
Zhang, Beibei
Zhou, Meng
Bei, Yu
Zhang, Yifan
Tang, Jianzhong
Yang, Yan
Huang, Yadong
Xiang, Qi
Zhao, Yueping
Liang, Qian
Liu, Yang
author_facet Liu, Yanmei
Yu, Fenglin
Zhang, Beibei
Zhou, Meng
Bei, Yu
Zhang, Yifan
Tang, Jianzhong
Yang, Yan
Huang, Yadong
Xiang, Qi
Zhao, Yueping
Liang, Qian
Liu, Yang
author_sort Liu, Yanmei
collection PubMed
description Injury to the peripheral nerves can result in temporary or life-long neuronal dysfunction and subsequent economic or social disability. Acidic fibroblast growth factor (aFGF) promotes the growth and survival of neurons and is a possible treatment for peripheral nerve injury. Yet, the actual therapeutic utility of aFGF is limited by its short half-life and instability in vivo. In the present study, we prepared sulfated chitooligosaccharides (SCOS), which have heparin-like properties, to improve the bioactivity of aFGF. We investigated the protective effects of SCOS with or without aFGF on RSC96 cells exposed to Na(2)S(2)O(4) hypoxia/reoxygenation injury. Cell viability was measured by MTT assay and cytotoxicity induced by Na(2)S(2)O(4) was assessed by lactate dehydrogenase (LDH) release into the culture medium. Pretreatment with aFGF and SCOS dramatically decreased LDH release after injury compared to pretreatment with aFGF or SCOS alone. We subsequently prepared an aFGF/SCOS thermo-sensitive hydrogel with poloxamer and examined its effects in vivo. Paw withdrawal thresholds and thermal withdrawal latencies were measured in rats with sciatic nerve injury. Local injection of the aFGF/SCOS hydrogels (aFGF: 40, 80 µg/kg) increased the efficiency of sciatic nerve repair compared to aFGF (80 µg/kg) hydrogel alone. Especially aFGF/SCOS thermo-sensitive hydrogel decreased paw withdrawal thresholds from 117.75 ± 8.38 (g, 4 d) to 65.74 ± 3.39 (g, 10 d), but aFGF alone group were 140.58 ± 27.54 (g, 4 d) to 89.12 ± 5.60 (g, 10 d) (aFGF dose was 80 µg/kg, P < 0.05, n = 8). The thermal withdrawal latencies decreased from 11.61 ± 2.26 (s, 4 d) to 2.37 ±0.67 (s, 10 d). However, aFGF alone group were from 17.69 ± 1.47 (s, 4 d) to 4.65 ± 1.73 (s, 10 d) (P < 0.05, n = 8). Furthermore, the aFGF/SCOS hydrogels also exhibited good biocompatibility in mice. In summary, SCOS improved the protective effects of aFGF in RSC96 cells injured with Na(2)S(2)O(4) and increased the efficiency of nerve repair and recovery of function in rats with sciatic nerve injury. These findings pave an avenue for the development of novel prophylactic and therapeutic strategies for peripheral nerve injury.
format Online
Article
Text
id pubmed-7032102
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Shenyang Pharmaceutical University
record_format MEDLINE/PubMed
spelling pubmed-70321022020-02-26 Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides Liu, Yanmei Yu, Fenglin Zhang, Beibei Zhou, Meng Bei, Yu Zhang, Yifan Tang, Jianzhong Yang, Yan Huang, Yadong Xiang, Qi Zhao, Yueping Liang, Qian Liu, Yang Asian J Pharm Sci Research Article Injury to the peripheral nerves can result in temporary or life-long neuronal dysfunction and subsequent economic or social disability. Acidic fibroblast growth factor (aFGF) promotes the growth and survival of neurons and is a possible treatment for peripheral nerve injury. Yet, the actual therapeutic utility of aFGF is limited by its short half-life and instability in vivo. In the present study, we prepared sulfated chitooligosaccharides (SCOS), which have heparin-like properties, to improve the bioactivity of aFGF. We investigated the protective effects of SCOS with or without aFGF on RSC96 cells exposed to Na(2)S(2)O(4) hypoxia/reoxygenation injury. Cell viability was measured by MTT assay and cytotoxicity induced by Na(2)S(2)O(4) was assessed by lactate dehydrogenase (LDH) release into the culture medium. Pretreatment with aFGF and SCOS dramatically decreased LDH release after injury compared to pretreatment with aFGF or SCOS alone. We subsequently prepared an aFGF/SCOS thermo-sensitive hydrogel with poloxamer and examined its effects in vivo. Paw withdrawal thresholds and thermal withdrawal latencies were measured in rats with sciatic nerve injury. Local injection of the aFGF/SCOS hydrogels (aFGF: 40, 80 µg/kg) increased the efficiency of sciatic nerve repair compared to aFGF (80 µg/kg) hydrogel alone. Especially aFGF/SCOS thermo-sensitive hydrogel decreased paw withdrawal thresholds from 117.75 ± 8.38 (g, 4 d) to 65.74 ± 3.39 (g, 10 d), but aFGF alone group were 140.58 ± 27.54 (g, 4 d) to 89.12 ± 5.60 (g, 10 d) (aFGF dose was 80 µg/kg, P < 0.05, n = 8). The thermal withdrawal latencies decreased from 11.61 ± 2.26 (s, 4 d) to 2.37 ±0.67 (s, 10 d). However, aFGF alone group were from 17.69 ± 1.47 (s, 4 d) to 4.65 ± 1.73 (s, 10 d) (P < 0.05, n = 8). Furthermore, the aFGF/SCOS hydrogels also exhibited good biocompatibility in mice. In summary, SCOS improved the protective effects of aFGF in RSC96 cells injured with Na(2)S(2)O(4) and increased the efficiency of nerve repair and recovery of function in rats with sciatic nerve injury. These findings pave an avenue for the development of novel prophylactic and therapeutic strategies for peripheral nerve injury. Shenyang Pharmaceutical University 2019-09 2018-11-01 /pmc/articles/PMC7032102/ /pubmed/32104478 http://dx.doi.org/10.1016/j.ajps.2018.09.007 Text en © 2018 Shenyang Pharmaceutical University. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Liu, Yanmei
Yu, Fenglin
Zhang, Beibei
Zhou, Meng
Bei, Yu
Zhang, Yifan
Tang, Jianzhong
Yang, Yan
Huang, Yadong
Xiang, Qi
Zhao, Yueping
Liang, Qian
Liu, Yang
Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides
title Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides
title_full Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides
title_fullStr Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides
title_full_unstemmed Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides
title_short Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides
title_sort improving the protective effects of afgf for peripheral nerve injury repair using sulfated chitooligosaccharides
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032102/
https://www.ncbi.nlm.nih.gov/pubmed/32104478
http://dx.doi.org/10.1016/j.ajps.2018.09.007
work_keys_str_mv AT liuyanmei improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT yufenglin improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT zhangbeibei improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT zhoumeng improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT beiyu improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT zhangyifan improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT tangjianzhong improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT yangyan improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT huangyadong improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT xiangqi improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT zhaoyueping improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT liangqian improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides
AT liuyang improvingtheprotectiveeffectsofafgfforperipheralnerveinjuryrepairusingsulfatedchitooligosaccharides